Supresta - analogs
Components: Mycophenolate mofetil |
|||||||||
Pharmgroups: Immunosuppressants |
|||||||||
| Prices in pharmacies: — Instructions Supresta | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . Clarithromycin ✘ (incl) Цинакальцет ПСК ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
| Similar | Complete analog ⓘ✘Analogues of the drug with completely identical active ingredients |
Prices in pharmacies |
| ≈100% | Negative 🔍 Mycophenolate mofetil | 19.8-23.2€ |
| ≈100% | Negative 🔍 Mycophenolate mofetil-TL | 21-22€ |
| ≈100% | Negative 🔍 Mycophenolate-Teva | 22.2-23€ |
| ≈100% | Negative 🔍 Mysept | 23€ |
| ≈100% | Negative 🔍 CellCept | 26.3-28.6€ |
| ≈100% | Negative 🔍 Flomiren | — |
| ≈100% | Negative 🔍 Mycophenolate Sandoz | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 66% — Mycophenolic acid neutral [Mycophenolic acid]
- 64% — Everolimus Dangerous 🔍 [Everolimus]
- 64% — Эвелирок Dangerous 🔍 [Everolimus]
- 64% — Сейвнови Dangerous 🔍 [Everolimus]
- 64% — Роливека Dangerous 🔍 [Everolimus]
- 64% — Олирамус Dangerous 🔍 [Everolimus]
- 64% — Эверолимус-промомед Dangerous 🔍 [Everolimus]
- 61% 34-38.1€ Феломика neutral [Mycophenolic acid]
- 61% — Mycophenolic acid-TL neutral [Mycophenolic acid]
- 61% — Никвесел neutral [Mycophenolic acid]
- 60% — Mycophenolate sodium neutral [Mycophenolic acid]
- 60% 44.1-54€ Myfortic neutral [Mycophenolic acid]
- 60% — Zenapax neutral [Daclizumab]
- 55% 430-531.2€ Simulect neutral [Basiliximab]
- 54% — Алвида Dangerous 🔍 [Everolimus]
- 54% — Трансаксепт Dangerous 🔍 [Everolimus]
- 54% — Сиролимус Dangerous 🔍 [Sirolimus]
- 50% 39.7-133.3€ Sertican Dangerous 🔍 [Everolimus]
- 50% — Эверолимус-АМЕДАРТ Dangerous 🔍 [Everolimus]
- 49% — ATG-Fresenius S neutral [Immunoglobulin antithymocyte]
- 49% — Thymoglobuline neutral [Immunoglobulin antithymocyte]
- 46% — Grafalon neutral [Immunoglobulin antithymocyte]
- 41% 320.2-513€ Rapamune Dangerous 🔍 [Sirolimus]
- 37% — Antilimpholint Kz Unclear 🔍 [Proteine]
- 36% — Микофеноловая кислота-промомед neutral [Mycophenolic acid]
- 34% — Antilimpholine neutral [Immunoglobulin antithymocyte]
- 33% — Такролимус-АМЕДАРТ Negative 🔍 [Tacrolimus]
- 33% — Лироктас Negative 🔍 [Tacrolimus]
- 33% — Grastiva Negative 🔍 [Tacrolimus]
- 33% 10.5€ Tacrolimus-Teva Negative 🔍 [Tacrolimus]
- 33% — Redinesp Negative 🔍 [Tacrolimus]
- 32% — Tacrolimus-Stada Negative 🔍 [Tacrolimus]
- 31% — Tacrolimus-Akri Negative 🔍 [Tacrolimus]
- 31% — Lenalidomide Canon Unclear 🔍 [Lenalidomide]
- 31% — Леноалромид Unclear 🔍 [Lenalidomide]
- 30% 11.5-24.5€ Tacrolimus Negative 🔍 [Tacrolimus]
- 29% — Пирфенидон-химрар neutral [Pirfenidone]
- 29% — Норсприлан neutral [Pirfenidone]
- 29% — Пирфенидон neutral [Pirfenidone]
- 29% — Пирфаспек neutral [Pirfenidone]
- 29% — Пирфенидон ПСК neutral [Pirfenidone]
- 29% — Esbriet neutral [Pirfenidone]
- 29% — Пирфенидон МИРФАРМ neutral [Pirfenidone]
- 29% 9-11.3€ Takrosel Negative 🔍 [Tacrolimus]
- 27% 9.2-151.9€ Prograf Negative 🔍 [Tacrolimus]
- 27% — Апварди neutral [Danicopan]
- 27% — Бонспри neutral [Ofatumumab]
- 27% — Скайризи neutral [Risankizumab]
- 27% 26.6€ Такролимус ретард-Тева Negative 🔍 [Tacrolimus]
- 27% 16-164.9€ Advagraf Negative 🔍 [Tacrolimus]
Learn more about the selection of analogues
▶
- The drug has «Supresta» 8 full analogs, the cheapest - Mycophenolate mofetil (19.8-23.2€); 51 analog by action, the most similar - Myfortic (44.1-54€).
- Medical online service has selected the best substitutes for Supresta based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Supresta to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.